|
|
Respiratory Agent
|
|
Bronchodilator
|
|
Bronchospasm
|
|
1. Adults: Not recommended. 2. Children: <2 yrs: not recommended. 2 yrs and over 1 vial by nebulizer 3-4 times daily over 5-15 minutes.
|
|
Category C
|
|
Tremor, nervousness, headache, dizziness, hyperactivity, insomnia, weakness, tachycardia, nasal bleeding, hypokalemia, local irritation, paradoxical bronchospasm, rash
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
|
|
|
If you want your friend to read or know about this article, Click here
|
|
|